BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30610455)

  • 1. Comparison of survival for cardiac resynchronization therapy in atrial fibrillation patients with or without atrio-ventricular junction ablation and patients in sinus rhythm: a systematic review and network meta-analysis.
    Xue Y; Wang J; Wang J; Thapa S; Huang K; Peng Y; Qian L; Li J; Ji K
    Heart Fail Rev; 2019 May; 24(3):335-342. PubMed ID: 30610455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).
    Gasparini M; Leclercq C; Lunati M; Landolina M; Auricchio A; Santini M; Boriani G; Lamp B; Proclemer A; Curnis A; Klersy C; Leyva F
    JACC Heart Fail; 2013 Dec; 1(6):500-7. PubMed ID: 24622002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations.
    Gasparini M; Kloppe A; Lunati M; Anselme F; Landolina M; Martinez-Ferrer JB; Proclemer A; Morani G; Biffi M; Ricci R; Rordorf R; Mangoni L; Manotta L; Grammatico A; Leyva F; Boriani G
    Eur J Heart Fail; 2018 Oct; 20(10):1472-1481. PubMed ID: 29251799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of atrioventricular junction ablation and CRT-D on long-term mortality in patients with left ventricular dysfunction, permanent, refractory atrial fibrillation, and narrow QRS: Results of a propensity-matched analysis.
    Palmisano P; Ziacchi M; Ammendola E; Dell'Era G; Guerra F; Donateo P; Del Giorno G; Laffi M; Coluccia G; Bartoli L; Gaggioli G; Carbone A; Senes J; Dello Russo A; Patti G; Nigro G; Biffi M; Accogli M
    J Cardiovasc Electrophysiol; 2022 Nov; 33(11):2288-2296. PubMed ID: 35930617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes After Ablation of the AV Junction in Patients With Atrial Fibrillation: Impact of Cardiac Resynchronization Therapy.
    Mittal S; Musat DL; Hoskins MH; Prillinger JB; Roberts GJ; Nabutovsky Y; Merchant FM
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29180458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Benefit of Atrioventricular Junction Ablation for Permanent Atrial Fibrillation and Heart Failure Patients Receiving Cardiac Resynchronization Therapy: An Updated Systematic Review and Meta-analysis.
    Waranugraha Y; Rizal A; Setiawan D; Aziz IJ
    Indian Pacing Electrophysiol J; 2021; 21(2):101-111. PubMed ID: 33548449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Junctional AV ablation in patients with atrial fibrillation undergoing cardiac resynchronization therapy (JAVA-CRT): results of a multicenter randomized clinical trial pilot program.
    Steinberg JS; Gorcsan J; Mazur A; Jain SK; Rashtian M; Greer GS; Zarraga I; Vloka M; Cook MM; Salam T; Mountantonakis S; Beck H; Silver J; Aktas M; Henrikson C; Schaller RD; Epstein AE; McNitt S; Schleede S; Peterson D; Goldenberg I; Zareba W
    J Interv Card Electrophysiol; 2022 Aug; 64(2):519-530. PubMed ID: 35043250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conversion CRT strategy combined with AVJA may be a perspective alternative for heart failure patients with persistent atrial fibrillation.
    Chen M; Dong Z; Zhang Y; Liu J; Zhang J
    Heart Fail Rev; 2023 Mar; 28(2):367-377. PubMed ID: 36662339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm.
    Jędrzejczyk-Patej E; Lenarczyk R; Pruszkowska P; Kowalski O; Mazurek M; Sokal A; Boidol J; Woźniak A; Pluta S; Szulik M; Liberska A; Kalarus Z
    Cardiol J; 2014; 21(3):309-15. PubMed ID: 23990182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation.
    Gasparini M; Auricchio A; Metra M; Regoli F; Fantoni C; Lamp B; Curnis A; Vogt J; Klersy C;
    Eur Heart J; 2008 Jul; 29(13):1644-52. PubMed ID: 18390869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chronic atrial fibrillation in patients with severe heart failure and indication for CRT: data of two registries with 711 patients (1999-2006 and 2007-6/2008).
    Luedorff G; Grove R; Kowalski M; Wolff E; Thale J; Kranig W
    Herzschrittmacherther Elektrophysiol; 2011 Dec; 22(4):226-32. PubMed ID: 22160274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation.
    Ferreira AM; Adragão P; Cavaco DM; Candeias R; Morgado FB; Santos KR; Santos E; Silva JA
    Europace; 2008 Jul; 10(7):809-15. PubMed ID: 18511438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review.
    Ganesan AN; Brooks AG; Roberts-Thomson KC; Lau DH; Kalman JM; Sanders P
    J Am Coll Cardiol; 2012 Feb; 59(8):719-26. PubMed ID: 22340263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy in patients with atrial fibrillation: a 2-year follow-up study.
    Eisen A; Nevzorov R; Goldenberg G; Kuznitz H; Porter A; Golovtziner G; Strasberg B; Haim M
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):872-7. PubMed ID: 23594360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does permanent atrial fibrillation modify response to cardiac resynchronization therapy in heart failure patients?
    Abreu A; Oliveira M; Silva Cunha P; Santa Clara H; Portugal G; Gonçalves Rodrigues I; Santos V; Morais L; Selas M; Soares R; Branco L; Ferreira R; Mota Carmo M;
    Rev Port Cardiol; 2017 Oct; 36(10):687-694. PubMed ID: 29031455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial Fibrillation During Cardiac Resynchronization Therapy.
    Kloosterman M; Maass AH; Rienstra M; Van Gelder IC
    Card Electrophysiol Clin; 2015 Dec; 7(4):735-48. PubMed ID: 26596815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to Improve Cardiac Resynchronization Therapy Benefit in Atrial Fibrillation Patients: Pulmonary Vein Isolation (and Beyond).
    Gianni C; Di Biase L; Mohanty S; Gökoğlan Y; Güneş MF; Al-Ahmad A; Burkhardt JD; Natale A
    Heart Fail Clin; 2017 Jan; 13(1):199-208. PubMed ID: 27886924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of atrial fibrillation on improvement of functional mitral regurgitation in cardiac resynchronization therapy.
    van der Bijl P; Vo NM; Leung M; Ajmone Marsan N; Delgado V; Stone GW; Bax JJ
    Heart Rhythm; 2018 Dec; 15(12):1816-1822. PubMed ID: 30017815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes after atrioventricular node ablation and biventricular pacing in patients with refractory atrial fibrillation and heart failure: a comparison between non-ischaemic and ischaemic cardiomyopathy.
    Sohinki D; Ho J; Srinivasan N; Collins LJ; Obel OA
    Europace; 2014 Jun; 16(6):880-6. PubMed ID: 24525552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to Improve Cardiac Resynchronization Therapy Benefit in Atrial Fibrillation Patients: Pulmonary Vein Isolation (and Beyond).
    Gianni C; Di Biase L; Mohanty S; Gökoğlan Y; Güneş MF; Al-Ahmad A; Burkhardt JD; Natale A
    Card Electrophysiol Clin; 2015 Dec; 7(4):755-64. PubMed ID: 26596817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.